OUR FOCUS
Creating Value-Driven Opportunities
Our highly-experienced investment bankers draw on their deep knowledge of the healthcare industry and unique market dynamics to help business leaders evaluate strategic alternatives and successfully execute complex, transformative transactions.
Our capabilities encompass both buy-side and sell-side advisory, strategic partnerships, joint ventures, and divestitures, including corporate carve-outs. Since 2009, we have completed 200+ M&A transactions with an aggregate value of $60B.
Recent Transactions
UNDISCLOSED
Financial Advisor
Asset Purchase Agreement with Genezen
July 2024
$135 Million Upfront + Up to $50M Contingent Payments
Exclusive Financial Advisor
U.S. Institutional Business Divested to Hikma Pharmaceuticals
Pending
UNDISCLOSED
Exclusive Financial Advisor
Merger with OnKure
Pending
UNDISCLOSED
Exclusive Financial Advisor
Acquisition of Tenet Medicines
Pending
